Corcept Therapeutics
Yahoo Finance • 14 days ago
Alger Russell Innovation Index Updates for Second Quarter 2026
NEW YORK, June 25, 2026 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close... Full story
Yahoo Finance • 22 days ago
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties t... Full story
Yahoo Finance • 30 days ago
Top Growth Companies With Insider Ownership In June 2026
Over the last 7 days, the United States market has experienced a 3.3% decline, yet it remains up by 22% over the past year with earnings anticipated to grow by 17% annually in the coming years. In this context, growth companies with substa... Full story
Yahoo Finance • last month
3 Growth Stocks With High Insider Ownership And 29% Revenue Growth
Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer uni... Full story
Yahoo Finance • last month
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
Key Points Invesco Pharmaceuticals ETF has a significantly lower five-year maximum drawdown and lower volatility profile than State Street SPDR S&P Biotech ETF State Street SPDR S&P Biotech ETF offers a more diversified approach with 151... Full story
Yahoo Finance • last month
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
The State Street SPDR S&P Pharmaceuticals ETF(NYSEMKT:XPH) offers a lower-cost entry into the drug manufacturing space, while the First Trust NYSE Arca Biotechnology Index Fund(NYSEMKT:FBT) provides concentrated exposure to biotechnology.... Full story
Yahoo Finance • last month
Spotlight On AppLovin And 2 More Growth Stocks With Significant Insider Stakes
The United States market has shown robust performance, climbing 1.2% in the last week and rising 27% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, growth companies... Full story
Yahoo Finance • last month
3 Growth Companies With High Insider Ownership And Up To 114% Earnings Growth
The United States market has shown robust performance, climbing 1.6% in the last 7 days and up 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider owner... Full story
Yahoo Finance • last month
High Insider Stakes In Leading Growth Companies May 2026
The United States market has shown robust performance, climbing 1.8% in the last 7 days and up 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider owner... Full story
Yahoo Finance • last month
Spotlight On 3 Growth Companies With Strong Insider Stakes
The United States market has shown robust performance with a 1.2% climb in the last week and a remarkable 29% increase over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. In this thriving en... Full story
Yahoo Finance • 2 months ago
S&P 500 and Nasdaq 100 Post New Record Highs on Chip Stock Strength
The S&P 500 Index ($SPX) (SPY) today is up +0.20%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.12%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.35%. Stock indexes today are mixed, with the S&P 500 and Nasdaq 100 posting n... Full story
Yahoo Finance • 2 months ago
Chip Stock Strength Lifts the Broader Market
The S&P 500 Index ($SPX) (SPY) today is up +0.18%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.58%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.60%. June E-mini S&P futures (ESM26) are up +0.12%, and June E-mini Nasdaq f... Full story
Yahoo Finance • 2 months ago
Stocks Pressured by Signs of Resurgent Inflation
The S&P 500 Index ($SPX) (SPY) today is down -0.19%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.47%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.05%. June E-mini S&P futures (ESM26) are down -0.20%, and June E-mini Nasd... Full story
Yahoo Finance • 2 months ago
Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli
Corcept Therapeutics Incorporated (NASDAQ:CORT) ranks among the most profitable biotech stocks to buy now. At the Society of Gynecologic Oncology Annual Meeting on April 10, Corcept Therapeutics Incorporated (NASDAQ:CORT) reported the conc... Full story
Yahoo Finance • 2 months ago
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: * Apple (AAPL [https://seekingalpha.com/symbol/AAPL]) * Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]) * Roku (ROKU [https://seekingalpha.com/symbol/ROKU]) * Twilio... Full story
Yahoo Finance • 2 months ago
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Jazz Pharmaceuticals (NASDAQ:JAZZ) and the best and worst performers in the pharma... Full story
Yahoo Finance • 2 months ago
Q4 Earnings Roundup: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Segment
Let’s dig into the relative performance of Merck (NYSE:MRK) and its peers as we unravel the now-completed Q4 branded pharmaceuticals earnings season. Looking ahead, the branded pharmaceutical industry is positioned for tailwinds from adva... Full story
Yahoo Finance • 3 months ago
A Look At Corcept Therapeutics (CORT) Valuation After FDA Approval Of Lifyorli And Positive ROSELLA Trial Results
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Corcept Therapeutics (CORT) is back in focus after the FDA approved Lifyorli for adults with plati... Full story
Yahoo Finance • 3 months ago
CORCEPT DEADLINE TOMORROW: Bragar Eagel & Squire, P.C. Urges Corcept Therapeutics Incorporated Investors to Contact the Firm Regarding Their Rights Before April 21st
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options If you purchased or acquired Corcept common stock between October 31... Full story
Yahoo Finance • 3 months ago
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
BENSALEM, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story